Our site uses cookies to improve the contents of the site and customize it according to individual use. Please confirm that you agree to our use of cookies by clicking Yes.

If you continue without explicit consent, we will assume that you agree to our cookie policy.

MEDISOA comprehensive portal site for
Medical Innovation Support Office (MEDISO).Medical Innovation Support Office

厚生労働省

Knowledgeable experts support the practical application of medicines, medical devices, and regenerative medicinal products.

2019年8月13日(火)~2019年8月15日(木)は、夏季休業とさせていただきます。
この期間中にお受けしたお問い合せ・ご相談の申込みについては、休業明けに対応させていただきます。
何卒ご了承のほどお願いいたします。

お知らせ

2018.03.01
Opend the New our homepage!

2019.08.08技術シーズに対する知財戦略策定支援の公募のお知らせ

NEWS

「技術シーズに対する知財戦略策定支援」の公募を開始致しました。

2019.08.01ジャパン・ヘルスケアベンチャー・サミット2019

NEWS

令和元年10月9日(水)~11日(金)の3日間、パシフィコ横浜にて「ジャパン・ヘルスケアベンチャー・サミット2019」が開催されます。

2019.08.01MEDISOセミナー&出前相談会 in 御茶ノ水 イベントレポート

REPORT

7月30日(火)TKPガーデンシティ御茶ノ水にて、セミナーと併せてMEDISOサポーターが相談に乗る「出前相談会」を実施しました。

2019.08.09MEDISOセミナー&出前相談会 in 御茶ノ水 セミナーレポート

REPORT

7月30日(火)TKPガーデンシティ御茶ノ水にて、セミナーを実施しました。

お知らせをもっと見る

What is MEDISO

MEDISO provides support for business ventures, academia,
and individuals intending to put into practical use medicines,
medical devices, and regenerative medicinal products.
Click here for further details.

About the Medical Innovation Support Office

The medical innovation support office matches medical venture companies and academic institutions facing challenges in the practical application of medical products and devices for specialists* who provide detailed consultation and support for solving problems at each stage from research and development to practical use, as well as insurance coverage at clinical sites, while looking ahead to the overall comprehensive advances and dissemination into the global market.
* Specialists in each field provide support for the response to laws and regulations, marketing, business planning, fund rasing, management strategy, intellectual property management, and international development, etc.

This website is operated by Mitsubishi Research Institute, Inc., as a trustee under instructions from the Economic Affairs Division, Health Policy Bureau, and Ministry of Health, Labour and Welfare as a part of the total support for the medical ventures program sponsored by the Ministry of Health, Labour and Welfare.

Support targets

Ventures, academic institutions, and individuals aiming to put into practical use the medicines, medical devices, regenerative medicinal products, and novel drug-discovery technologies or medical materials subject to the Pharmaceuticals and Medical Devices Law.

Details of support

MEDISO provides support for the practical application of medicines, medical devices, regenerative medicinal products, and other products subject to the Pharmaceuticals and Medical Devices Law.
That support includes business planning, financing, advice on laws and regulations, and other assistance as required.

Click here for inquiries and consultation requests

Specialists Introduction

We will introduce registered specialists
(updated as necessary).

Hiroaki Kato

Visiting Professor, The Graduate School of the Digital Hollywood University

Main specialty areas

  • medicines
  • medical devices
  • regenerative medicine products

Specialized support fields

  • Regulatory compliance
  • Marketing
  • Business planning
  • Funding
  • Business operation systems

He is a former government official of the Ministry of Health, Labour and Welfare and is working as a doctor specialized in digital health, including telemedicine, AI, and IoT. As an ophthalmologist, he has experience in more than 1,500 surgical operations. He developed instruments for cataract operations and ophthalmic consultation services.

He is a rare person who has experience in three areas—medical practice, medical systems, and business—which are required for medical care and the healthcare business, and he understands these areas, providing support for the development of new business covering the full range of medical care. He is also familiar with Japanese medical venture companies and works as a consultant, advisor, and director for large enterprises and venture companies. He wrote 41 books, including Medical Care 4.0 — Medical Care in the Fourth Industrial Revolution Era—.

Koji Yoshida

Representative Director, Luminov Inc.

Main specialty areas

  • medical devices

Specialized support fields

  • Regulatory compliance
  • Marketing
  • Business planning
  • Funding
  • Business operation systems
  • Specialized support fields

After graduation from university, he was involved in marketing at the world's biggest foreign-affiliated manufacturer of artificial joint for 20 years. After he experienced the role of a leader of unit with a budget of 15 billion yen, he launched his own business in 2014. He established Luminov Inc., which specializes in the development, manufacturing, and sales of medical devices. In 2017, he planned a medical-industrial cooperation event on consignment from a public entity. He held workshops for companies who entered this industry from different industries. Products newly developed at these workshops were highly regarded, having won a second prize in an international event associated with medical care devices. Furthermore, the unique strategy for developing medical devices that uses workshops and medical care products originated from these workshops were frequently quoted in the media.

Tomoko Nakatani

Prezio IP Firm

Main specialty areas

  • medicines
  • regenerative medicine products

Specialized support fields

  • Specialized support fields

She graduated from the Department of Life Science and Technology, School of Bioscience and Biotechnology, Tokyo Institute of Technology. After working at a research institute of Sankyo Company, Limited, she gained experience in intellectual property about low molecular weight compounds and biopharmaceuticals in the Intellectual Property Department. Subsequently, she was in charge of intellectual property assessment and investment and intellectual property consulting about investment destinations at biotechnology venture capital firms. For the purpose of providing support for strengthening intellectual property in biotech venture companies, she moved to a patent attorney's office, where she supported intellectual property strategies and human resources development in addition to application and procedures at the Japan Patent Office of biotech venture companies and universities. She has more than 10 years of experience supporting intellectual property of venture companies and universities with her strong interest in putting into practical use research seeds by effectively gaining patent rights.

Tamaki Nara

Director, Olvis Planning Co., Ltd.

Main specialty areas

  • medicines
  • medical devices
  • regenerative medicine products

Specialized support fields

  • Regulatory compliance
  • Marketing
  • Business planning
  • Funding
  • Business operation systems
  • Specialized support fields

She graduated from the Department of English Literature, School of Humanities, Kansei Gakuin University (English and Sociology) and graduated from Business Breakthrough University (Management and Marketing). She worked in the international department of a city bank, lived in the UK, and then worked for a leading precision equipment maker. She devoted almost five years to making plans for new project and management for digital equipment and then devoted almost ten years to providing planning and development and making plans for management for new field products in medical devices and healthcare (medical IT) projects. Especially during this period, she felt great significance in establishing a collaborative development system with medical-based researchers while experiencing the bodily sensations of strength, weakness, joy, a feeling of achievement, and challenges in developing new business in medical devices and healthcare in companies. This experience made her give guidance about medical device development and open innovation establishment. Since then about four years have passed and her role has not changed.
Paper: Cancer and Chemotherapy, 2015, joint work
Title: Development of Support System for Breast Cancer Patients,
Managing Side Effects Through an Internet-based System, etc.
Lecture:
A Symposium for innovation through collaboration between industry and academia in Waseda University and Kobe University
Collaboration Between Industry and Academia in the Development of Medical Devices in Our Company—from an experience of accepting an internship of a doctor from the School of Medicine, Kobe University.

Hidehiro Ando

Representative, Andy Pharma Partners

Main specialty areas

  • medicines
  • medical devices
  • regenerative medicine products

Specialized support fields

  • Business operation systems

He graduated from the Department of Veterinary Medical Science, Faculty of Agriculture, University of Tokyo. He joined Tanabe Pharma Corporation (present Mitsubishi Tanabe Pharma Corporation). After being assigned to the research department of pharmacokinetics, he was involved in partnership-related business of international development department, research and development planning department, etc., including establishment of a joint venture with overseas companies. Subsequently, he worked in the technology transfer department of RIKEN (Institute of Physical and Chemical Research), a regenerative medicine venture, Bayer Yakuhin, a drug discovery venture, and he established a personal office. He has engaged in business development and licensing work for about 35 years, and now, based on his experience and networks, he is supporting business development activities, such as licensing agreements and joint research of domestic and foreign pharmaceutical companies/ventures. He provides comprehensive support services ranging from looking for appropriate partners, preparing the draft of contract outline, contract negotiation, and alliance management with partners after the partnership agreement. Especially, based on experience of practicing on both sides of venture and pharmaceutical companies, he keeps in mind providing informative advice and proposals for specific action plans.

About details of specialists

Introduction of measures implemented by public institutions

We will describe the measures from public institutions for pharmaceutical companies,
medical device companies, companies manufacturing regenerative medicinal products, and venture companies.

See more about measures implemented by public institutions